Successful treatment of chronic hand eczema with oral 9-cis-retinoic acid

Dermatology

Volumn 199, Issue 4, 1999, Pages 308-312

  Bollag, Werner ^a   Ott, F ^b  

^a Scientific Department   (Switzerland)

^b NONE

Author keywords

9 cis retinoic acid; Chronic hand eczema; Retinoids

Indexed keywords

ALITRETINOIN; RETINOIC ACID RECEPTOR; RETINOID;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEILITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONJUNCTIVITIS; DRUG EFFICACY; DRUG RECEPTOR BINDING; FEMALE; FLUSHING; HAND ECZEMA; HEADACHE; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0033457350     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018280     Document Type: Article

References (17)

1. Bollag W: Vitamin A and retinoids: From nutrition to pharmacotherapy in dermatology and oncology. Lancet 1983;i:860-863.
2. Orfanos CE, Zouboulis CC, Almond B, Geilen CC: Current use and future potential role of retinoids in dermatology. Drugs 1997;53:358-388.
3. Bollag W: Retinoids and interferon-α in the prevention and treatment of preneoplastic and neoplastic diseases: A review. Retinoids Today Tomorrow 1995;40:26-31.
4. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G, Speck J, Kratzeisen CL, Rosenherger M, Lovey A, Grippo JF: 9-cis-Retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature 1992;355:359-361.
5. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, Thaller C: 9-cis-Retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 1992;68:397-406.
6. Bollag W, Isnardi L, Jablonska S, Klaus M, Majewski S, Pirson W, Toma S: Links between pharmacological properties of retinoids and nuclear retinoid receptors. Int J Cancer 1997; 70:470-472.
7. Gottardis MM, Lamph WW, Shalinsky DR, Wellstein A, Heyman RA: The efficacy of 9-cis retinoic acid in experimental models of cancer. Breast Cancer Res Treat 1996;38:85-96.
8. Miller WH Jr, Jakubowski A; Tong WP, Miller VA, Rigas JR, Benedetti F, Gill GM, Truglia JA, Ulm E, Shirley M, Warrell RP: 9-cis-Retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia. Blood 1995;81:3021-3027.
9. Kurie JM; Lee JS, Griffin T, Lippman SM, Drum P, Thomas MP, Weher C, Bader M, Massimini G, Hong WK: Phase I trial of 9-cis retinoic acid in adults with solid tumors. Clin Cancer Res 1996;2:287-293.
10. Miller VA, Rigas JR, Benedetti FM, Verret AL, Tong WP, Kris MG, Gill GM, Loewen GR, Truglia JA, Ulm EH, Warrell RP: Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid. Clin Cancer Res 1996;2:471-475.
11. Ott F, Bollag W, Geiger JM: Oral 9-cis retinoic acid versus 13-cis retinoic acid in acne therapy. Dermatology 1996;193:124-126.
12. Ross AC, Hämmerling UG: Retinoids and the immune system; in Sporn MB, Roberts AB, Goodman DS (eds): The Retinoids: Biology, Chemistry and Medicine, ed 2. New York, Raven Press, 1994, pp 521-543.
13. Burton JL, Holden CA: Eczema, lichenification and prurigo: Hand eczema; in Champion RH, Burton JL, Bums DA, Breathnach SM (eds): Textbook of Dermatology, Oxford, Blackwell Scientific Publications, 1998, pp 648-658.
14. Mosman TR, Coffman RL: Th1 and Th2 cells: Different pattern of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-174.
15. Druet P, Sheela R, Pelletier L: Th1 and Th2 cells in autoimmunity; in Romagnani S (ed): Th1 and Th2 Cells in Health and Disease. Chem Immunol. Basel, Karger, 1996, vol 63, pp 158-170.
16. Robinson DS, Kay AB: Role of Th1 and Th2 cells in human allergic disorders; in Romagnani S (ed): Th1 and Th2 Cells in Health and Disease. Chem Immunol. Basel, Karger, 1996, vol 63, pp 187-203.
17. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes, Nature 1996;383:787-793.